Rank | Gene Set | Z-score |
---|---|---|
1 | cellular potassium ion homeostasis (GO:0030007) | 5.52837911 |
2 | sodium ion export (GO:0071436) | 4.98038296 |
3 | gonadal mesoderm development (GO:0007506) | 4.79677400 |
4 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.70283987 |
5 | locomotory exploration behavior (GO:0035641) | 4.66862915 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.65051913 |
7 | synaptic vesicle exocytosis (GO:0016079) | 4.52243467 |
8 | chemosensory behavior (GO:0007635) | 4.45409136 |
9 | righting reflex (GO:0060013) | 4.36628729 |
10 | glutamate secretion (GO:0014047) | 4.34608120 |
11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.33414493 |
12 | neuronal ion channel clustering (GO:0045161) | 4.14484624 |
13 | vocalization behavior (GO:0071625) | 4.13717309 |
14 | synaptic vesicle maturation (GO:0016188) | 4.10636968 |
15 | dendritic spine morphogenesis (GO:0060997) | 4.06084480 |
16 | thyroid hormone generation (GO:0006590) | 4.04812496 |
17 | cell communication by electrical coupling (GO:0010644) | 4.03343780 |
18 | activation of protein kinase A activity (GO:0034199) | 4.02833236 |
19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.02765585 |
20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.94536821 |
21 | neuronal action potential propagation (GO:0019227) | 3.92034659 |
22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.90756955 |
23 | positive regulation of protein sumoylation (GO:0033235) | 3.84535714 |
24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.84391756 |
25 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.83759720 |
26 | cellular sodium ion homeostasis (GO:0006883) | 3.79082743 |
27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.77749288 |
28 | C4-dicarboxylate transport (GO:0015740) | 3.77546800 |
29 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.74861533 |
30 | synaptic transmission, glutamatergic (GO:0035249) | 3.74454159 |
31 | glutamate receptor signaling pathway (GO:0007215) | 3.73700288 |
32 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.73262930 |
33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.73035718 |
34 | potassium ion homeostasis (GO:0055075) | 3.73000634 |
35 | dendritic spine organization (GO:0097061) | 3.70014816 |
36 | gamma-aminobutyric acid transport (GO:0015812) | 3.68315589 |
37 | neurotransmitter secretion (GO:0007269) | 3.67340169 |
38 | potassium ion import (GO:0010107) | 3.66030942 |
39 | amino acid import (GO:0043090) | 3.57694717 |
40 | thyroid hormone metabolic process (GO:0042403) | 3.56655884 |
41 | L-amino acid import (GO:0043092) | 3.56488068 |
42 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.55467103 |
43 | protein K11-linked deubiquitination (GO:0035871) | 3.51389204 |
44 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.49058028 |
45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48866214 |
46 | detection of calcium ion (GO:0005513) | 3.48646987 |
47 | neuron-neuron synaptic transmission (GO:0007270) | 3.47314896 |
48 | desmosome organization (GO:0002934) | 3.45403314 |
49 | alanine transport (GO:0032328) | 3.39456997 |
50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.39039359 |
51 | regulation of synaptic vesicle transport (GO:1902803) | 3.36577249 |
52 | cerebellar granule cell differentiation (GO:0021707) | 3.35684670 |
53 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.35240273 |
54 | response to histamine (GO:0034776) | 3.34849502 |
55 | neuromuscular process controlling posture (GO:0050884) | 3.34803993 |
56 | membrane repolarization (GO:0086009) | 3.32754678 |
57 | exploration behavior (GO:0035640) | 3.32070775 |
58 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30058918 |
59 | cerebellar Purkinje cell layer development (GO:0021680) | 3.29269996 |
60 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.28868576 |
61 | response to auditory stimulus (GO:0010996) | 3.27856262 |
62 | long-term synaptic potentiation (GO:0060291) | 3.27584256 |
63 | proline transport (GO:0015824) | 3.24684615 |
64 | protein localization to synapse (GO:0035418) | 3.23858459 |
65 | regulation of beta-amyloid formation (GO:1902003) | 3.22518477 |
66 | long-term memory (GO:0007616) | 3.20323787 |
67 | regulation of cell communication by electrical coupling (GO:0010649) | 3.20304478 |
68 | positive regulation of synapse maturation (GO:0090129) | 3.19874516 |
69 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.18876684 |
70 | layer formation in cerebral cortex (GO:0021819) | 3.18537933 |
71 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.16678716 |
72 | L-serine transport (GO:0015825) | 3.16619787 |
73 | neurotransmitter transport (GO:0006836) | 3.12481385 |
74 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.12386525 |
75 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.10466647 |
76 | transmission of nerve impulse (GO:0019226) | 3.09613419 |
77 | positive regulation of dendritic spine development (GO:0060999) | 3.08579723 |
78 | regulation of synapse structural plasticity (GO:0051823) | 3.07777380 |
79 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.07154198 |
80 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.07036049 |
81 | neuron cell-cell adhesion (GO:0007158) | 3.00388860 |
82 | regulation of synaptic plasticity (GO:0048167) | 2.99912779 |
83 | auditory behavior (GO:0031223) | 2.96690339 |
84 | axon ensheathment in central nervous system (GO:0032291) | 2.95630456 |
85 | central nervous system myelination (GO:0022010) | 2.95630456 |
86 | cardiac conduction (GO:0061337) | 2.95551446 |
87 | tooth mineralization (GO:0034505) | 2.94303167 |
88 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93789185 |
89 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92338787 |
90 | membrane repolarization during action potential (GO:0086011) | 2.92015358 |
91 | negative regulation of hormone metabolic process (GO:0032351) | 2.91616227 |
92 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.91616227 |
93 | long term synaptic depression (GO:0060292) | 2.91019267 |
94 | regulation of protein sumoylation (GO:0033233) | 2.89688255 |
95 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.89339087 |
96 | cAMP biosynthetic process (GO:0006171) | 2.88060898 |
97 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.86786547 |
98 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.85447308 |
99 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.85266939 |
100 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.85266939 |
101 | regulation of neurotransmitter levels (GO:0001505) | 2.84932010 |
102 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.84918908 |
103 | regulation of vesicle fusion (GO:0031338) | 2.84003380 |
104 | acid secretion (GO:0046717) | 2.83821190 |
105 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.80862454 |
106 | positive regulation of potassium ion transport (GO:0043268) | 2.79812039 |
107 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.78494803 |
108 | neuromuscular process controlling balance (GO:0050885) | 2.76748032 |
109 | positive regulation of protein targeting to membrane (GO:0090314) | 2.76596328 |
110 | glycine transport (GO:0015816) | 2.75488099 |
111 | neurotransmitter uptake (GO:0001504) | 2.73323206 |
112 | * cellular potassium ion transport (GO:0071804) | 2.73264318 |
113 | * potassium ion transmembrane transport (GO:0071805) | 2.73264318 |
114 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.72864849 |
115 | regulation of dendritic spine development (GO:0060998) | 2.72660886 |
116 | innervation (GO:0060384) | 2.72315143 |
117 | synapse assembly (GO:0007416) | 2.71887535 |
118 | response to dietary excess (GO:0002021) | 2.71539798 |
119 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.70228669 |
120 | cell communication involved in cardiac conduction (GO:0086065) | 2.70136338 |
121 | membrane hyperpolarization (GO:0060081) | 2.69642365 |
122 | regulation of postsynaptic membrane potential (GO:0060078) | 2.69332968 |
123 | myelin maintenance (GO:0043217) | 2.68837622 |
124 | positive regulation of neurotransmitter transport (GO:0051590) | 2.68247393 |
125 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.67609424 |
126 | sodium ion homeostasis (GO:0055078) | 2.67579138 |
127 | synaptic vesicle endocytosis (GO:0048488) | 2.67174349 |
128 | regulation of neurotransmitter transport (GO:0051588) | 2.66601634 |
129 | positive regulation of sodium ion transport (GO:0010765) | 2.65928655 |
130 | cellular response to glucagon stimulus (GO:0071377) | 2.65339564 |
131 | cochlea development (GO:0090102) | 2.64243222 |
132 | * synaptic transmission (GO:0007268) | 2.63999027 |
133 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.63886880 |
134 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.63609266 |
135 | signal release (GO:0023061) | 2.62195156 |
136 | regulation of synapse maturation (GO:0090128) | 2.61555681 |
137 | negative regulation of sodium ion transport (GO:0010766) | 2.61456735 |
138 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.61388205 |
139 | negative regulation of dendrite development (GO:2000171) | 2.60330810 |
140 | positive regulation of membrane potential (GO:0045838) | 2.60036949 |
141 | dendrite morphogenesis (GO:0048813) | 2.59470259 |
142 | serine transport (GO:0032329) | 2.58781770 |
143 | mechanosensory behavior (GO:0007638) | 2.56726600 |
144 | regulation of neurotransmitter secretion (GO:0046928) | 2.56337858 |
145 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.55918686 |
146 | negative regulation of astrocyte differentiation (GO:0048712) | 2.55714464 |
147 | acidic amino acid transport (GO:0015800) | 2.52947559 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.48047851 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.61267641 |
3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16608447 |
4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.13047393 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03477885 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99557354 |
7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73824587 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.72592275 |
9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63605205 |
10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59029914 |
11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59029914 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58541815 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55244016 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52739673 |
15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51640976 |
16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45815284 |
17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43741186 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.35238880 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33299662 |
20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32656292 |
21 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.32422311 |
22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.27490394 |
23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.20881366 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16154101 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11606487 |
26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10047048 |
27 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08628694 |
28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07277158 |
29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.06433256 |
30 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.02479751 |
31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97496605 |
32 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.96600362 |
33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.85494909 |
34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80233217 |
35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69069384 |
36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65851262 |
37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.63782860 |
38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.55198049 |
39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.53174097 |
40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48829480 |
41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47837132 |
42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44855739 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42707161 |
44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39795227 |
45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38545497 |
46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37241763 |
47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36132999 |
48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33375684 |
49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31855276 |
50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31555077 |
51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30150621 |
52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29458678 |
53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28167666 |
54 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27637878 |
55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.26851024 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26834178 |
57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25762402 |
58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25666966 |
59 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25138372 |
60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21929255 |
61 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.20666136 |
62 | * AR_19668381_ChIP-Seq_PC3_Human | 1.20427262 |
63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19373722 |
64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18876787 |
65 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17243471 |
66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15948334 |
67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15146120 |
68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14897586 |
69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13958502 |
70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12860759 |
71 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12499009 |
72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11550743 |
73 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.11093075 |
74 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10440377 |
75 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09919322 |
76 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.09789499 |
77 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09641127 |
78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09623470 |
79 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08062174 |
80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08061234 |
81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07335914 |
82 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04880771 |
83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.04401731 |
84 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03694741 |
85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03651650 |
86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03646777 |
87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03271332 |
88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03113991 |
89 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.02358045 |
90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01602756 |
91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00714737 |
92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00298513 |
93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97272072 |
94 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96593575 |
95 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.96037109 |
96 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95720805 |
97 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95652029 |
98 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95082714 |
99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.94347435 |
100 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94197176 |
101 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92917288 |
102 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92350534 |
103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91777190 |
104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91415872 |
105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91351976 |
106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90976887 |
107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90912327 |
108 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90604532 |
109 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.90591407 |
110 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90398156 |
111 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90273729 |
112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90254006 |
113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90209032 |
114 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89481724 |
115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88915840 |
116 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.88503648 |
117 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88133850 |
118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86907039 |
119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86884462 |
120 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.86299057 |
121 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86148178 |
122 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86028722 |
123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85630424 |
124 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84807634 |
125 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84770494 |
126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84550029 |
127 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84492471 |
128 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83240732 |
129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81772647 |
130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81269764 |
131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81232053 |
132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80348328 |
133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.79655858 |
134 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79487175 |
135 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.78353083 |
136 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77864773 |
137 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.76850346 |
138 | VDR_22108803_ChIP-Seq_LS180_Human | 0.75199559 |
139 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.74895352 |
140 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73398086 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.93627261 |
2 | MP0003635_abnormal_synaptic_transmissio | 3.42830517 |
3 | MP0003880_abnormal_central_pattern | 3.19701861 |
4 | MP0004270_analgesia | 2.95401832 |
5 | MP0009745_abnormal_behavioral_response | 2.87861892 |
6 | MP0009046_muscle_twitch | 2.76501855 |
7 | MP0004885_abnormal_endolymph | 2.75908084 |
8 | MP0002064_seizures | 2.69961000 |
9 | MP0002063_abnormal_learning/memory/cond | 2.68763517 |
10 | MP0004043_abnormal_pH_regulation | 2.65590013 |
11 | MP0001486_abnormal_startle_reflex | 2.47863167 |
12 | MP0009780_abnormal_chondrocyte_physiolo | 2.44577690 |
13 | MP0003329_amyloid_beta_deposits | 2.39237219 |
14 | MP0002572_abnormal_emotion/affect_behav | 2.38976291 |
15 | MP0001968_abnormal_touch/_nociception | 2.38795961 |
16 | MP0002272_abnormal_nervous_system | 2.24289902 |
17 | MP0002734_abnormal_mechanical_nocicepti | 2.23006911 |
18 | MP0000579_abnormal_nail_morphology | 2.20763722 |
19 | MP0004858_abnormal_nervous_system | 2.20525107 |
20 | MP0001440_abnormal_grooming_behavior | 2.20061193 |
21 | MP0005646_abnormal_pituitary_gland | 2.13682023 |
22 | MP0002736_abnormal_nociception_after | 2.12241503 |
23 | MP0002909_abnormal_adrenal_gland | 2.09079907 |
24 | MP0001501_abnormal_sleep_pattern | 2.07323758 |
25 | MP0008569_lethality_at_weaning | 1.95360726 |
26 | MP0003123_paternal_imprinting | 1.90254369 |
27 | MP0002067_abnormal_sensory_capabilities | 1.87018766 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.82651302 |
29 | MP0001502_abnormal_circadian_rhythm | 1.82027758 |
30 | MP0002733_abnormal_thermal_nociception | 1.81897714 |
31 | MP0002735_abnormal_chemical_nociception | 1.81576404 |
32 | MP0005084_abnormal_gallbladder_morpholo | 1.73240492 |
33 | MP0002557_abnormal_social/conspecific_i | 1.71189980 |
34 | MP0002796_impaired_skin_barrier | 1.67240794 |
35 | MP0002822_catalepsy | 1.66563303 |
36 | MP0001970_abnormal_pain_threshold | 1.64703642 |
37 | MP0005423_abnormal_somatic_nervous | 1.58952549 |
38 | MP0001984_abnormal_olfaction | 1.58085708 |
39 | MP0001485_abnormal_pinna_reflex | 1.53783790 |
40 | MP0003690_abnormal_glial_cell | 1.47176762 |
41 | MP0003879_abnormal_hair_cell | 1.41310490 |
42 | MP0010386_abnormal_urinary_bladder | 1.40748753 |
43 | MP0001664_abnormal_digestion | 1.38686625 |
44 | MP0000003_abnormal_adipose_tissue | 1.38266428 |
45 | MP0005386_behavior/neurological_phenoty | 1.37833843 |
46 | MP0004924_abnormal_behavior | 1.37833843 |
47 | MP0003633_abnormal_nervous_system | 1.37220248 |
48 | MP0000566_synostosis | 1.37003946 |
49 | MP0002184_abnormal_innervation | 1.33984293 |
50 | MP0003183_abnormal_peptide_metabolism | 1.32465004 |
51 | MP0004147_increased_porphyrin_level | 1.29499221 |
52 | MP0002254_reproductive_system_inflammat | 1.29273933 |
53 | MP0010678_abnormal_skin_adnexa | 1.28494688 |
54 | MP0000778_abnormal_nervous_system | 1.28236462 |
55 | MP0005377_hearing/vestibular/ear_phenot | 1.27952536 |
56 | MP0003878_abnormal_ear_physiology | 1.27952536 |
57 | MP0001765_abnormal_ion_homeostasis | 1.27180115 |
58 | MP0000955_abnormal_spinal_cord | 1.22561067 |
59 | MP0002066_abnormal_motor_capabilities/c | 1.19156491 |
60 | MP0002882_abnormal_neuron_morphology | 1.18620997 |
61 | MP0003941_abnormal_skin_development | 1.16263757 |
62 | MP0001944_abnormal_pancreas_morphology | 1.15325090 |
63 | MP0003631_nervous_system_phenotype | 1.14255035 |
64 | MP0004019_abnormal_vitamin_homeostasis | 1.10368344 |
65 | MP0004811_abnormal_neuron_physiology | 1.09752095 |
66 | MP0004742_abnormal_vestibular_system | 1.09731417 |
67 | MP0000920_abnormal_myelination | 1.09519841 |
68 | MP0000681_abnormal_thyroid_gland | 1.09047490 |
69 | MP0000604_amyloidosis | 1.08441713 |
70 | MP0002876_abnormal_thyroid_physiology | 1.06943864 |
71 | MP0003075_altered_response_to | 1.05818211 |
72 | MP0008872_abnormal_physiological_respon | 1.04452284 |
73 | MP0000013_abnormal_adipose_tissue | 1.03911308 |
74 | MP0000462_abnormal_digestive_system | 1.03560349 |
75 | MP0001963_abnormal_hearing_physiology | 1.03531093 |
76 | MP0003634_abnormal_glial_cell | 1.03282695 |
77 | MP0005551_abnormal_eye_electrophysiolog | 0.99021375 |
78 | MP0003632_abnormal_nervous_system | 0.96453089 |
79 | MP0003283_abnormal_digestive_organ | 0.96388254 |
80 | MP0002152_abnormal_brain_morphology | 0.95756841 |
81 | MP0002229_neurodegeneration | 0.94934471 |
82 | MP0004142_abnormal_muscle_tone | 0.93205877 |
83 | MP0001177_atelectasis | 0.93030724 |
84 | MP0002069_abnormal_eating/drinking_beha | 0.91540065 |
85 | MP0005645_abnormal_hypothalamus_physiol | 0.89693299 |
86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.88752087 |
87 | MP0005501_abnormal_skin_physiology | 0.88531874 |
88 | MP0000678_abnormal_parathyroid_gland | 0.87843280 |
89 | MP0001348_abnormal_lacrimal_gland | 0.87231103 |
90 | MP0006072_abnormal_retinal_apoptosis | 0.86996464 |
91 | MP0010771_integument_phenotype | 0.84907304 |
92 | MP0004264_abnormal_extraembryonic_tissu | 0.84610775 |
93 | MP0005623_abnormal_meninges_morphology | 0.82065872 |
94 | MP0008004_abnormal_stomach_pH | 0.81366076 |
95 | MP0001881_abnormal_mammary_gland | 0.81298305 |
96 | MP0005448_abnormal_energy_balance | 0.81089427 |
97 | MP0000537_abnormal_urethra_morphology | 0.80754426 |
98 | MP0001299_abnormal_eye_distance/ | 0.80697345 |
99 | MP0000631_abnormal_neuroendocrine_gland | 0.80523686 |
100 | MP0001346_abnormal_lacrimal_gland | 0.80216308 |
101 | MP0003787_abnormal_imprinting | 0.79855975 |
102 | MP0002090_abnormal_vision | 0.79814643 |
103 | MP0004215_abnormal_myocardial_fiber | 0.79326275 |
104 | MP0000026_abnormal_inner_ear | 0.77148490 |
105 | MP0005332_abnormal_amino_acid | 0.74867320 |
106 | MP0000762_abnormal_tongue_morphology | 0.74538822 |
107 | MP0005394_taste/olfaction_phenotype | 0.73674745 |
108 | MP0005499_abnormal_olfactory_system | 0.73674745 |
109 | MP0003137_abnormal_impulse_conducting | 0.73478472 |
110 | MP0005379_endocrine/exocrine_gland_phen | 0.72676841 |
111 | MP0001188_hyperpigmentation | 0.72367489 |
112 | MP0001905_abnormal_dopamine_level | 0.71940032 |
113 | MP0002638_abnormal_pupillary_reflex | 0.71062626 |
114 | MP0000534_abnormal_ureter_morphology | 0.71009148 |
115 | MP0002089_abnormal_postnatal_growth/wei | 0.70619662 |
116 | MP0002653_abnormal_ependyma_morphology | 0.69955172 |
117 | MP0003122_maternal_imprinting | 0.69859338 |
118 | MP0008874_decreased_physiological_sensi | 0.69837010 |
119 | MP0005220_abnormal_exocrine_pancreas | 0.66602136 |
120 | MP0002234_abnormal_pharynx_morphology | 0.66463591 |
121 | MP0002752_abnormal_somatic_nervous | 0.65904952 |
122 | MP0005535_abnormal_body_temperature | 0.65681961 |
123 | MP0004133_heterotaxia | 0.65527014 |
124 | MP0002693_abnormal_pancreas_physiology | 0.65242734 |
125 | MP0008961_abnormal_basal_metabolism | 0.65020739 |
126 | MP0005165_increased_susceptibility_to | 0.64129038 |
127 | MP0003953_abnormal_hormone_level | 0.63717493 |
128 | MP0004145_abnormal_muscle_electrophysio | 0.63362606 |
129 | MP0002078_abnormal_glucose_homeostasis | 0.63066340 |
130 | MP0003638_abnormal_response/metabolism_ | 0.62521380 |
131 | MP0002160_abnormal_reproductive_system | 0.61040218 |
132 | MP0002098_abnormal_vibrissa_morphology | 0.60146111 |
133 | MP0001756_abnormal_urination | 0.59255210 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.23622668 |
2 | Myokymia (HP:0002411) | 4.70181023 |
3 | Epileptic encephalopathy (HP:0200134) | 4.29511124 |
4 | Focal seizures (HP:0007359) | 4.05563985 |
5 | Visual hallucinations (HP:0002367) | 3.88963616 |
6 | Megalencephaly (HP:0001355) | 3.81805854 |
7 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.76232498 |
8 | Aplasia of the phalanges of the hand (HP:0009802) | 3.76232498 |
9 | Aplasia involving bones of the extremities (HP:0009825) | 3.76232498 |
10 | Atonic seizures (HP:0010819) | 3.75884550 |
11 | Action tremor (HP:0002345) | 3.56620356 |
12 | Febrile seizures (HP:0002373) | 3.43782229 |
13 | Progressive cerebellar ataxia (HP:0002073) | 3.35247450 |
14 | Absence seizures (HP:0002121) | 3.20672398 |
15 | Metabolic alkalosis (HP:0200114) | 3.19091064 |
16 | Hemiplegia (HP:0002301) | 3.15361561 |
17 | Onycholysis (HP:0001806) | 3.10707356 |
18 | Hemiparesis (HP:0001269) | 3.09751206 |
19 | Increased circulating renin level (HP:0000848) | 3.06701849 |
20 | Hyperactive renin-angiotensin system (HP:0000841) | 3.05911158 |
21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.00447340 |
22 | Generalized tonic-clonic seizures (HP:0002069) | 2.91311290 |
23 | Neurofibrillary tangles (HP:0002185) | 2.87460740 |
24 | Cerebral hypomyelination (HP:0006808) | 2.86044797 |
25 | Dialeptic seizures (HP:0011146) | 2.84184039 |
26 | Abnormality of binocular vision (HP:0011514) | 2.80623433 |
27 | Diplopia (HP:0000651) | 2.80623433 |
28 | Goiter (HP:0000853) | 2.77625311 |
29 | Hypokalemic alkalosis (HP:0001949) | 2.75905974 |
30 | Tetraplegia (HP:0002445) | 2.75336479 |
31 | Status epilepticus (HP:0002133) | 2.72286423 |
32 | Scanning speech (HP:0002168) | 2.71629000 |
33 | Dysdiadochokinesis (HP:0002075) | 2.68025968 |
34 | Right ventricular cardiomyopathy (HP:0011663) | 2.67935900 |
35 | Torticollis (HP:0000473) | 2.66891368 |
36 | Hyperventilation (HP:0002883) | 2.66207893 |
37 | Cerebral inclusion bodies (HP:0100314) | 2.64621326 |
38 | Abnormality of the dental pulp (HP:0006479) | 2.63411804 |
39 | Focal dystonia (HP:0004373) | 2.59175289 |
40 | Hyperaldosteronism (HP:0000859) | 2.58505876 |
41 | Truncal ataxia (HP:0002078) | 2.55443030 |
42 | Abnormality of renal excretion (HP:0011036) | 2.55229118 |
43 | Supranuclear gaze palsy (HP:0000605) | 2.55014364 |
44 | Abnormal eating behavior (HP:0100738) | 2.52348330 |
45 | Abnormal urine output (HP:0012590) | 2.48450788 |
46 | Gout (HP:0001997) | 2.44699234 |
47 | Gaze-evoked nystagmus (HP:0000640) | 2.42835135 |
48 | Pili torti (HP:0003777) | 2.41175793 |
49 | Anxiety (HP:0000739) | 2.37267755 |
50 | Abnormality of cochlea (HP:0000375) | 2.37033291 |
51 | Polyuria (HP:0000103) | 2.36393950 |
52 | Ventricular fibrillation (HP:0001663) | 2.35719118 |
53 | Split foot (HP:0001839) | 2.34757355 |
54 | Postural tremor (HP:0002174) | 2.34584356 |
55 | Depression (HP:0000716) | 2.33903765 |
56 | Double outlet right ventricle (HP:0001719) | 2.31273350 |
57 | Congenital malformation of the right heart (HP:0011723) | 2.31273350 |
58 | Choreoathetosis (HP:0001266) | 2.29757416 |
59 | Dysmetria (HP:0001310) | 2.26254914 |
60 | Hypomagnesemia (HP:0002917) | 2.26154230 |
61 | Broad-based gait (HP:0002136) | 2.24255873 |
62 | Syncope (HP:0001279) | 2.23495091 |
63 | Renal salt wasting (HP:0000127) | 2.22936410 |
64 | Potter facies (HP:0002009) | 2.22784348 |
65 | Facial shape deformation (HP:0011334) | 2.22784348 |
66 | Abnormality of saccadic eye movements (HP:0000570) | 2.21556307 |
67 | Spastic gait (HP:0002064) | 2.20297564 |
68 | Abnormality of chloride homeostasis (HP:0011422) | 2.19820333 |
69 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19182609 |
70 | Overgrowth (HP:0001548) | 2.17965345 |
71 | Plantar hyperkeratosis (HP:0007556) | 2.17571030 |
72 | Synostosis involving the elbow (HP:0003938) | 2.17551940 |
73 | Humeroradial synostosis (HP:0003041) | 2.17551940 |
74 | Akinesia (HP:0002304) | 2.17070705 |
75 | Intention tremor (HP:0002080) | 2.16681178 |
76 | Craniofacial dystonia (HP:0012179) | 2.16168675 |
77 | Abnormality of renin-angiotensin system (HP:0000847) | 2.14343444 |
78 | Hyperthyroidism (HP:0000836) | 2.14220537 |
79 | Bundle branch block (HP:0011710) | 2.14071232 |
80 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.12314461 |
81 | Sensory axonal neuropathy (HP:0003390) | 2.11757426 |
82 | Amelogenesis imperfecta (HP:0000705) | 2.10254169 |
83 | Poor eye contact (HP:0000817) | 2.09784939 |
84 | Impaired smooth pursuit (HP:0007772) | 2.08172137 |
85 | Tetany (HP:0001281) | 2.08126617 |
86 | Abnormality of dental color (HP:0011073) | 2.07678316 |
87 | Postural instability (HP:0002172) | 2.07218616 |
88 | Impaired social interactions (HP:0000735) | 2.05577495 |
89 | Abnormal social behavior (HP:0012433) | 2.05577495 |
90 | Clumsiness (HP:0002312) | 2.05514026 |
91 | Abnormal hair laboratory examination (HP:0003328) | 2.05315199 |
92 | Hypokinesia (HP:0002375) | 2.04661578 |
93 | Epileptiform EEG discharges (HP:0011182) | 2.03247616 |
94 | Abnormality of renal resorption (HP:0011038) | 2.02229328 |
95 | Abnormality of magnesium homeostasis (HP:0004921) | 2.02133158 |
96 | Abnormality of nail color (HP:0100643) | 1.99460142 |
97 | Polydipsia (HP:0001959) | 1.98278785 |
98 | Abnormal drinking behavior (HP:0030082) | 1.98278785 |
99 | Neuronal loss in central nervous system (HP:0002529) | 1.97374262 |
100 | Pheochromocytoma (HP:0002666) | 1.96087163 |
101 | Chronic bronchitis (HP:0004469) | 1.95499749 |
102 | Hyperphosphatemia (HP:0002905) | 1.94813184 |
103 | Lip pit (HP:0100267) | 1.94546121 |
104 | Hypoglycemic seizures (HP:0002173) | 1.91900298 |
105 | Diminished movement (HP:0002374) | 1.91070203 |
106 | Bronchomalacia (HP:0002780) | 1.90519273 |
107 | Limb dystonia (HP:0002451) | 1.90466938 |
108 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89960941 |
109 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.89293229 |
110 | Abnormality of the corticospinal tract (HP:0002492) | 1.88634171 |
111 | Impaired vibratory sensation (HP:0002495) | 1.88049268 |
112 | Morphological abnormality of the inner ear (HP:0011390) | 1.85475134 |
113 | Genetic anticipation (HP:0003743) | 1.84615915 |
114 | Rigidity (HP:0002063) | 1.83995972 |
115 | Horizontal nystagmus (HP:0000666) | 1.83692833 |
116 | Ketoacidosis (HP:0001993) | 1.82924903 |
117 | Fragile nails (HP:0001808) | 1.81124268 |
118 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.81096645 |
119 | Obstructive sleep apnea (HP:0002870) | 1.80629434 |
120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.80484239 |
121 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79678098 |
122 | Ankle clonus (HP:0011448) | 1.79361905 |
123 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.78956776 |
124 | Limb ataxia (HP:0002070) | 1.78773566 |
125 | Stereotypic behavior (HP:0000733) | 1.78651495 |
126 | Amblyopia (HP:0000646) | 1.78528664 |
127 | Decreased circulating renin level (HP:0003351) | 1.76492133 |
128 | Adrenal overactivity (HP:0002717) | 1.75869824 |
129 | Hypsarrhythmia (HP:0002521) | 1.75494887 |
130 | Bradykinesia (HP:0002067) | 1.74771692 |
131 | Incomplete penetrance (HP:0003829) | 1.74426788 |
132 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.73912374 |
133 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.73912374 |
134 | Palmoplantar hyperkeratosis (HP:0000972) | 1.73110114 |
135 | Villous atrophy (HP:0011473) | 1.72398494 |
136 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.72398494 |
137 | Osteomalacia (HP:0002749) | 1.71960983 |
138 | Clonus (HP:0002169) | 1.71026946 |
139 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.70441684 |
140 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.70441684 |
141 | Abnormality of the salivary glands (HP:0010286) | 1.70397072 |
142 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.68217655 |
143 | Athetosis (HP:0002305) | 1.68069824 |
144 | Gait ataxia (HP:0002066) | 1.68033690 |
145 | Mixed hearing impairment (HP:0000410) | 1.67337745 |
146 | Confusion (HP:0001289) | 1.65838472 |
147 | Neuroendocrine neoplasm (HP:0100634) | 1.65642539 |
148 | Hypokalemia (HP:0002900) | 1.64943715 |
149 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.63653825 |
150 | Dysmetric saccades (HP:0000641) | 1.63532171 |
151 | Urinary urgency (HP:0000012) | 1.63392684 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 5.09120290 |
2 | NTRK3 | 3.78435222 |
3 | LMTK2 | 3.18871216 |
4 | MST1R | 2.89252690 |
5 | MAP3K9 | 2.73381570 |
6 | MAP3K4 | 2.35697960 |
7 | DAPK2 | 2.28836808 |
8 | MINK1 | 2.18429598 |
9 | OXSR1 | 2.16105599 |
10 | MAP2K7 | 1.88461609 |
11 | WNK3 | 1.86320916 |
12 | CASK | 1.81138211 |
13 | AKT3 | 1.78421255 |
14 | NTRK2 | 1.73058014 |
15 | MAP3K2 | 1.71089164 |
16 | TNIK | 1.70464619 |
17 | RIPK4 | 1.64981119 |
18 | KSR2 | 1.64516194 |
19 | STK38 | 1.60719234 |
20 | PHKG2 | 1.60188178 |
21 | PHKG1 | 1.60188178 |
22 | WNK4 | 1.59102085 |
23 | MET | 1.58078699 |
24 | NTRK1 | 1.48366697 |
25 | PRKD3 | 1.48295563 |
26 | CAMKK1 | 1.47347974 |
27 | MAP2K4 | 1.41591764 |
28 | MAP3K12 | 1.40284048 |
29 | PAK6 | 1.35076155 |
30 | SGK223 | 1.33276618 |
31 | SGK494 | 1.33276618 |
32 | CAMKK2 | 1.32179548 |
33 | STK39 | 1.31291601 |
34 | SGK2 | 1.27400806 |
35 | DAPK1 | 1.27322556 |
36 | CDK19 | 1.25195385 |
37 | CDK5 | 1.20577217 |
38 | FER | 1.17999245 |
39 | FRK | 1.15459495 |
40 | NME1 | 1.14989128 |
41 | PRKCG | 1.13399628 |
42 | BRSK1 | 1.08896922 |
43 | KSR1 | 1.08774094 |
44 | RIPK1 | 1.07350854 |
45 | PBK | 1.04901833 |
46 | STK3 | 1.04522934 |
47 | SGK3 | 1.04457385 |
48 | MARK1 | 1.04287507 |
49 | PRPF4B | 1.03798000 |
50 | MST4 | 1.01405274 |
51 | PLK2 | 1.00294629 |
52 | STK24 | 0.95036270 |
53 | PINK1 | 0.94299178 |
54 | SCYL2 | 0.93144212 |
55 | TESK1 | 0.91722639 |
56 | WNK1 | 0.91605141 |
57 | STK38L | 0.89194257 |
58 | CAMK2A | 0.89181228 |
59 | FGFR2 | 0.89044001 |
60 | CAMK2B | 0.86463678 |
61 | BRAF | 0.86130616 |
62 | GRK5 | 0.85198233 |
63 | TRIB3 | 0.83901843 |
64 | MUSK | 0.83001091 |
65 | EPHA2 | 0.81481538 |
66 | DAPK3 | 0.80683097 |
67 | TNK2 | 0.80520335 |
68 | MAP3K13 | 0.76815266 |
69 | ARAF | 0.75076361 |
70 | SGK1 | 0.74575012 |
71 | BMPR2 | 0.74364461 |
72 | CAMK1 | 0.73689370 |
73 | PAK3 | 0.72065183 |
74 | CAMK2G | 0.71272707 |
75 | PNCK | 0.70988766 |
76 | SIK1 | 0.69269419 |
77 | MAPK13 | 0.68650910 |
78 | PTK2 | 0.68263520 |
79 | DYRK1A | 0.68199623 |
80 | TSSK6 | 0.68112688 |
81 | PRKCE | 0.67601272 |
82 | ROCK2 | 0.66001030 |
83 | TLK1 | 0.65780063 |
84 | RET | 0.65317636 |
85 | PDK4 | 0.65129713 |
86 | PDK3 | 0.65129713 |
87 | MAP2K1 | 0.65076614 |
88 | NEK6 | 0.63425996 |
89 | IRAK2 | 0.62428344 |
90 | INSRR | 0.60850709 |
91 | TYRO3 | 0.58975891 |
92 | EIF2AK1 | 0.58749530 |
93 | PDPK1 | 0.58156928 |
94 | ADRBK1 | 0.57820532 |
95 | AKT2 | 0.57623908 |
96 | CAMK2D | 0.57404918 |
97 | PDK2 | 0.57084505 |
98 | ALK | 0.56980298 |
99 | DDR2 | 0.56949075 |
100 | CDK18 | 0.56898862 |
101 | PRKG2 | 0.56176238 |
102 | CDK15 | 0.55314034 |
103 | NME2 | 0.53797986 |
104 | LATS2 | 0.52222330 |
105 | CDK14 | 0.51700551 |
106 | PTK2B | 0.51640458 |
107 | STK16 | 0.51083246 |
108 | MAPK12 | 0.50153247 |
109 | TTK | 0.49705285 |
110 | CDC42BPA | 0.48888898 |
111 | MAP3K7 | 0.46793549 |
112 | TRIM28 | 0.46566715 |
113 | LIMK1 | 0.46362549 |
114 | CDK11A | 0.44440081 |
115 | PRKCH | 0.43418925 |
116 | CAMK1G | 0.43358357 |
117 | ZAK | 0.42889819 |
118 | PDK1 | 0.42560802 |
119 | CSNK1A1 | 0.42306450 |
120 | MAP3K1 | 0.41824117 |
121 | NEK1 | 0.41387825 |
122 | PRKCA | 0.40866784 |
123 | PAK4 | 0.40567941 |
124 | PRKCI | 0.40374860 |
125 | MARK2 | 0.40305953 |
126 | ROCK1 | 0.39488980 |
127 | UHMK1 | 0.39486787 |
128 | MAP2K6 | 0.39484628 |
129 | CSNK1E | 0.39437481 |
130 | STK11 | 0.39258395 |
131 | RPS6KA3 | 0.37910467 |
132 | EIF2AK3 | 0.37365384 |
133 | CSNK1G2 | 0.34562173 |
134 | BMX | 0.34310762 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.35544151 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.78997424 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.75132888 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.51558190 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31648043 |
6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28794236 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.22582600 |
8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.21327723 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.20667949 |
10 | Salivary secretion_Homo sapiens_hsa04970 | 2.18004473 |
11 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.16479484 |
12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.14440341 |
13 | Insulin secretion_Homo sapiens_hsa04911 | 2.03466035 |
14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.97825668 |
15 | Morphine addiction_Homo sapiens_hsa05032 | 1.95407763 |
16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.94371841 |
17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.93586250 |
18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.88549547 |
19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85409690 |
20 | Taste transduction_Homo sapiens_hsa04742 | 1.77930278 |
21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.73182770 |
22 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.68541372 |
23 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.62405107 |
24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56812069 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38048426 |
26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35458368 |
27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34997872 |
28 | Renin secretion_Homo sapiens_hsa04924 | 1.34874192 |
29 | Long-term depression_Homo sapiens_hsa04730 | 1.33671217 |
30 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31358203 |
31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27741883 |
32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.25646878 |
33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25077957 |
34 | Mineral absorption_Homo sapiens_hsa04978 | 1.19394067 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19131015 |
36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16790506 |
37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16270618 |
38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14331701 |
39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09688804 |
40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07284597 |
41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07038836 |
42 | Bile secretion_Homo sapiens_hsa04976 | 1.06976032 |
43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01232535 |
44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01035892 |
45 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98516851 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98126063 |
47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.96565891 |
48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95428363 |
49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94986872 |
50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94301008 |
51 | Gap junction_Homo sapiens_hsa04540 | 0.94295351 |
52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94277443 |
53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90681652 |
54 | Melanogenesis_Homo sapiens_hsa04916 | 0.90188061 |
55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86893079 |
56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85938928 |
57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85684526 |
58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85649242 |
59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85586472 |
60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84250871 |
61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.81865911 |
62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79527893 |
63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78808937 |
64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75997983 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74411437 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72931200 |
67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72504783 |
68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71378037 |
69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70790524 |
70 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65692217 |
71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65559185 |
72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64914915 |
73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64608433 |
74 | Glioma_Homo sapiens_hsa05214 | 0.63612384 |
75 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63152873 |
76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62441323 |
77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60654955 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59010199 |
79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58539916 |
80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58168253 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54356191 |
82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54047779 |
83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52649760 |
84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52528104 |
85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52503271 |
86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51676500 |
87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51607730 |
88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51007674 |
89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49911426 |
90 | Alcoholism_Homo sapiens_hsa05034 | 0.49377848 |
91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49292305 |
92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48871215 |
93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48041717 |
94 | Tight junction_Homo sapiens_hsa04530 | 0.47466027 |
95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47386067 |
96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46730800 |
97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45264519 |
98 | Axon guidance_Homo sapiens_hsa04360 | 0.45127170 |
99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43508882 |
100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42666899 |
101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41579896 |
102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.41575720 |
103 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37955233 |
104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37097194 |
105 | Lysosome_Homo sapiens_hsa04142 | 0.35571621 |
106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35531195 |
107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35472118 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35070307 |
109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33415450 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.32230013 |
111 | Protein export_Homo sapiens_hsa03060 | 0.31703557 |
112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.31054215 |
113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.30944721 |
114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30839901 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30523320 |
116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30101805 |
117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28769699 |
118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.28729602 |
119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28443859 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28301545 |
121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27363060 |
122 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.27176732 |
123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25794639 |
124 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25472098 |
125 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.25168292 |
126 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24968676 |
127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24461266 |
128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23981864 |